Publication Type:

Journal Article

Source:

Asian J Oncology (2020)

Abstract:

Diffuse large B-cell lymphoma (DLBCL) accounts for 60% of lymphomas in India. Although the survival of DLBCL patients has improved following the addition of rituximab, a subset of patients do not respond well to therapy. Among the several factors responsible for this varied response, tumor microenvironment is considered to be crucial. This study is a search for such prognostic markers in the tumor microenvironment.

Cite this Research Publication

Dr. Pavithran K., RN, I., S, A., and P, P., “Immunohistochemical Markers of Tumor Microenvironment as Prognostic Predictors in Diffuse Large B-Cell Lymphoma: Study from an Oncology Centre in South India”, Asian J Oncology, 2020.

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat or click here to download the PDF file.